创新药概念盘初走强 三生国健20CM2连板

Group 1 - The core viewpoint of the article highlights the strong performance of innovative drug concepts, particularly the significant rise of Sanofi's stock, which has achieved a 20% increase for two consecutive trading days [1] - The announcement from Sanofi indicates a licensing agreement with related parties, including Sanofi Pharmaceutical and Shenyang Sanofi, for exclusive global development, production, and commercialization rights for product 707 in collaboration with Pfizer [1] - Other companies in the sector, such as Yipinhong, Shutaishen, XinNuoWei, Yifang Biotechnology, Kexing Pharmaceutical, and Rejing Biotechnology, also experienced stock price increases of over 10% [1]